Violation Tracker Parent Company Summary

Parent Company Name: 
Mylan
Ownership Structure: 
publicly traded (ticker symbol MYL)
Headquartered in: 
Netherlands (reincorporated for tax reasons)
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$1,099,772,700
Number of records: 
34
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
government-contracting-related offenses$960,447,70027
consumer-protection-related offenses$100,250,0002
financial offenses$30,000,0001
competition-related offenses$8,600,0002
healthcare-related offenses$250,0001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act and related$960,447,70027
consumer protection violation$100,250,0002
investor protection violation$30,000,0001
price-fixing or anti-competitive practices$8,000,0001
fraud$600,0001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

Dey Labs; Dey LP; Dey Pharmaceuticals; Dey, Inc.; Mylan Inc.; Mylan Laboratories et al.; Mylan Laboratories Inc.; Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.; Mylan N.V.; MYLAN PHARMACEUTICALS AND UDL LABS; Mylan Pharmaceuticals, Inc.; Mylan Specialty, L.P.

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Typesort icon Year Agency Penalty Amount
Mylan Laboratories, Inc. consumer protection violation 2000 FTC $100,000,000
Mylan Specialty L.P. consumer protection violation 2013 OR-AG $250,000
Dey Inc. False Claims Act and related 2010 DOJ_CIVIL $280,000,000
Mylan Pharmaceuticals and UDL Laboratories False Claims Act and related 2009 DOJ_CIVIL $118,000,000
Dey, Inc. False Claims Act and related 2003 DOJ_CIVIL $18,500,000
Mylan Inc. False Claims Act and related 2017 DOJ_CIVIL $465,000,000
Dey False Claims Act and related 2012 LA-AG $3,000,000
Dey Inc. False Claims Act and related 2005 CT-AG $2,500,000
Dey Inc. False Claims Act and related 2006 MO-AG $2,932,000
Dey Inc. False Claims Act and related 2006 OH-AG $4,000,000
Dey Inc. False Claims Act and related 2004 WV-AG $850,000
Dey L.P. False Claims Act and related 2008 AL-AG $4,750,000
Dey Labs False Claims Act and related 2009 MS-AG $3,900,000
Dey LP False Claims Act and related 2007 MT-AG $198,000
Dey Pharmaceuticals False Claims Act and related 2011 PA-AG $2,000,000
Dey, Inc. False Claims Act and related 2007 HI-AG $1,150,000
Dey, Inc. False Claims Act and related 2009 IA-AG $1,800,000
Dey, Inc. False Claims Act and related 2006 ID-AG $1,072,700
Dey, Inc. False Claims Act and related 2010 KY-AG $3,500,000
Dey, Inc. False Claims Act and related 2007 MA-AG $2,900,000
Dey, Inc. False Claims Act and related 2007 NV-AG $670,000
Dey, Inc. False Claims Act and related 2003 TX-AG $9,000,000
Dey, Inc. False Claims Act and related 2010 WI-AG $2,000,000
Mylan Inc. False Claims Act and related 2017 MULTI-AG (*) $465,000,000
Mylan Inc. False Claims Act and related 2010 MA-AG $2,600,000
Mylan Laboratories Inc. False Claims Act and related 2010 TX-AG $23,000,000
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. False Claims Act and related 2012 ID-AG $625,000
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. False Claims Act and related 2011 KY-AG $6,500,000
Mylan Pharmaceuticals, Inc. False Claims Act and related 2009 MULTI-AG (*) $118,000,000
Dey, Inc. fraud 2004 AR-AG $600,000
Mylan N.V. investor protection violation 2019 SEC $30,000,000
Mylan Specialty, L.P. off-label or unapproved promotion of medical products 2013 MA-AG $250,000
Mylan Laboratories et al. price-fixing or anti-competitive practices 2000 MULTI-AG (*) $108,000,000
Mylan wage and hour violation 2014 private lawsuit-federal $225,000
Download results as CSV or XML